Search Results for: stem cells for ms

Mitalipov Nature pub review: IPSC & SCNT for mitochondrial disease

/ / 6 Comments
Mitalipov-IPSC-paper

In a new, thought-provoking paper today in Nature, Shoukhrat Mitalipov and a multi-institutional team report a significant advance toward potential novel ways to treat mitochondrial diseases. What are these illnesses? Mitochondrial diseases are rare, but devastating disorders caused by genetic mutations. Today they are largely impossible to treat in meaningful ways other than palliative care. Some […]

Mitalipov Nature pub review: IPSC & SCNT for mitochondrial disease Read More »

Masayo Takahashi (高橋 政代) on IPSC Trial for Vision

/ / 9 Comments
Monkey-stem-cell-RPEs

Masayo Takahashi (高橋 政代) on IPSC Trial for Macular Degeneration By Michael Cea Stem Cell Analyst & Advocate (editor’s note: piece was originally posted on Michael’s blog here; follow Michael on Twitter @msemporda) Masayo Takahashi interview Having followed closely the developments in programs using pluripotent based therapeutics I was fortunate during ISSCR2015 to have the opportunity to

Masayo Takahashi (高橋 政代) on IPSC Trial for Vision Read More »

Interview with transhumanism leader Maria Konovalenko

/ / 21 Comments
Maria-Konovalenko

The transhumanism movement has been garnering attention lately for a variety of views including embracing aspects of heritable human genetic modification. Earlier this year I interviewed geneticist and transhumanist, George Church. In this post I interview molecular biophysicist and transhumanist Maria Konovalenko. She is the program coordinator at the Science for Life Extension Foundation. In

Interview with transhumanism leader Maria Konovalenko Read More »

Monday morning musings: stocks, ISSCR, grants, CRISPR, New Book

/ / 5 Comments
Wake-up-its-Monday

What’s on your mind on this Monday morning and are you caffeinated enough yet? Depending on where you live it may even be time for dinner, bed, or already early Tuesday. Here are some Monday musings… To get safe and effective stem cell treatments to patients in a responsible, compliant manner you need commercial efforts

Monday morning musings: stocks, ISSCR, grants, CRISPR, New Book Read More »

Guest Post by Chris Scott–The Great CRISPR Controversy: What’s Next?

/ / 1 Comment
CRISPR-primates

A decade ago I wrote an article in the journal Nature Biotechnology about the rise of a new gene editing technology called zinc finger nucleases (ZNF). It was one of those “drumbeat” discoveries: at the time, my sense was it would revolutionize how we deliver genes to cells and tissues, and profoundly change the way

Guest Post by Chris Scott–The Great CRISPR Controversy: What’s Next? Read More »

Do Patients Have a Fundamental Right to Choice?

/ / 9 Comments
right-to-choice-in-medicine

What is the “proper” amount of freedom of choice for patients in medicine? What if the treatments in question are experimental and come with their own baggage of associated risks, personal costs, and potential costs to society? More broadly, do patients have a fundamental right to medical choice? These questions seem particularly appropriate today on

Do Patients Have a Fundamental Right to Choice? Read More »

Statins dilemma: heart & cancer benefits, but diabetes risk

/ / 7 Comments
statin_drugs

Statins have been hailed as some of the best drugs ever. Given the massive, deadly prevalence of cardiovascular disease, some have even semi-jokingly talked about putting these drugs in the water supply for public health. The growing evidence (e.g. this story) that statins might significantly aid in prevention, delayed progression, or even post-treatment delay of

Statins dilemma: heart & cancer benefits, but diabetes risk Read More »